Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
AMRN | AMARIN CORP PLCUK | Reilly Thomas Charles | EVP and CFO | Jan 31, 2024 | Option Exercise | $1.24 | 24,552 | 30,444 | 68,931 | Feb 02, 2024, 04:30 PM | |
AMRN | AMARIN CORP PLCUK | Reilly Thomas Charles | EVP and CFO | Jan 10, 2024 | Option Exercise | $0.97 | 28,325 | 27,475 | 48,550 | Jan 12, 2024, 05:27 PM | |
AMRN | AMARIN CORP PLCUK | Reilly Thomas Charles | SVP and CFO | Jul 01, 2023 | Option Exercise | $1.19 | 8,209 | 9,769 | 25,375 | Jul 05, 2023, 04:46 PM | |
AMRN | AMARIN CORP PLCUK | Reilly Thomas Charles | SVP and CFO | Jun 20, 2023 | Option Exercise | $1.19 | 16,417 | 19,536 | 16,917 | Jun 22, 2023, 05:10 PM | |
CARA | Cara Therapeutics, Inc. | Reilly Thomas Charles | Chief Financial Officer | Mar 03, 2022 | Sale | $11.38 | 2,044 | 23,261 | 37,811 | Mar 04, 2022, 05:54 PM | |
CARA | Cara Therapeutics, Inc. | Reilly Thomas Charles | Chief Financial Officer | Aug 30, 2021 | Sale | $14.20 | 1,982 | 28,144 | 3,352 | Sep 01, 2021, 06:08 PM |